354 studies found for:    small cell lung ca | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Conditions: Small Cell Lung Carcinoma;   Non Small Cell Lung Carcinoma;   Irinotecan Sensitive Cancers
Interventions: Drug: Carfilzomib;   Drug: Irinotecan
2 Recruiting The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
Condition: Extensive Stage Small Cell Lung Cancer
Intervention: Biological: Ipilimumab
3 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
4 Recruiting A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Device: Liposomal Doxorubicin Combined With ifosfamide
5 Recruiting BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer;   Small Cell Lung Cancer Recurrent
Intervention: Drug: BIBF 1120
6 Not yet recruiting Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas
Conditions: Small Cell Lung Cancer (SCLC);   Neuroendocrine (NE) Tumors;   Large Cell Neuroendocrine (NE) Tumors
Intervention: Drug: Rhenium Re 188-P2045
7 Recruiting Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Radiation: Adaptive Radiation
8 Recruiting Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Interventions: Drug: topotecan hydrochloride;   Drug: cyclodextrin-based polymer-camptothecin CRLX101
9 Recruiting A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Small Cell Lung Carcinoma;   Malignant Epithelial Neoplasms
Interventions: Drug: (Belinostat) (PDX101);   Drug: Cisplatin;   Drug: Etoposide
10 Recruiting SC16LD6.5 in Recurrent Small Cell Lung Cancer
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: SC16LD6.5
11 Recruiting Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Large Cell Lung Cancer;   Metastatic Carcinoma of Unknown Primary;   Neuroendocrine Carcinoma;   Newly Diagnosed Carcinoma of Unknown Primary;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: veliparib;   Other: placebo;   Drug: etoposide;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Other: questionnaire administration
12 Recruiting Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy
Condition: Extensive Stage Small Cell Lung Cancer
Intervention: Procedure: bioelectric impedance analysis
13 Recruiting Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: Topotecan and Pasireotide
14 Recruiting A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: cisplatinum or carboplatin and e.g.etoposide.;   Drug: cisplatinum or carboplatin and e.g.etoposide+enoxaparin
15 Recruiting Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Condition: Recurrent Small Cell Lung Cancer
Interventions: Drug: veliparib;   Drug: temozolomide;   Other: placebo;   Other: laboratory biomarker analysis
16 Recruiting CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid
17 Recruiting Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Condition: Lung Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: etoposide
18 Recruiting A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Cisplatin in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE)
Condition: Stage IV Small Cell Lung Cancer
Interventions: Drug: OMP-59R5;   Drug: Etoposide;   Drug: Placebo;   Drug: Cisplatin
19 Recruiting Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Biological: Autologous cytokine-induced killer cell;   Other: Best Supportive Care
20 Recruiting Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Biological: HLA-A*2402-restricted CDCA1 and KIF20A peptides

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years